Carlye Group makes $4.15B offer for J&J business
Johnson & Johnson is being offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business.
The New Brunswick, N.J., company has until the end of March to decide whether to accept the offer. Johnson & Johnson executives will discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing that unit's employees before making a decision.
The Ortho-Clinical business makes equipment for screening blood supplies and detecting and diagnosing conditions such as HIV, diabetes and high cholesterol. The company said a year ago that it was exploring alternatives such as a sale or spinoff for that business.
Company shares are up 25 cents, to $95.05, in premarket trading.